Table 2.
Distribution of LOC387715-G/T among Cases and Controls from the AREDS and NEI Protocols
Geograpihic Atrophy
|
Choroidal Neovascularization
|
Combined
|
||||||
---|---|---|---|---|---|---|---|---|
Genotypes | Control | Case | P | OR (95%CI) vs. GG | P | OR (95%CI) vs. GG | P | OR (95%CI) vs. GG |
GG | 217 (66.0%) | 148 (37.1%) | Reference | 1 | Reference | 1 | Reference | 1 |
GT | 100 (30.4%) | 182 (45.6%) | 3.40 × 10−7 | 2.87 (1.91–4.30) | 2.29 × 10−6 | 2.48(1.70–3.61) | 1.42 × 10−9 | 2.61 (1.89–3.61) |
TT | 12 (3.65%) | 69 (17.3%) | 1.73 × 10−6 | 6.43 (3.00–13.79) | 2.39 × 10−11 | 10.12(5.12–20.01) | 3.56 × 10−13 | 8.59 (4.49–16.46) |
GT+TT | 112(34.0%) | 251 (69.2%) | 2.07 × 10−8 | 3.24 (2.20–4.78) | 2.92 × 10−10 | 3.0 (2.32–4.70) | 9.06 × 10−15 | 3.25 (2.39–4.41) |
G | 534 (81.2%) | 478 (59.9%) | Reference | 1 | Reference | 1 | Reference | 1 |
T | 124 (18.8%) | 320 (40.1%) | 3.97 × 10−11 | 2.64 (1.97–3.54) | 5.46 × 10−17 | 3.10(2.37–4.06) | 1.80 × 10−18 | 2.88 (2.26–3.67) |